Diagnostic Pathology Services, Inc., commonly referred to as DPS, is a leading provider of diagnostic pathology solutions headquartered in the United States. Established in [year founded], the company has made significant strides in the pathology industry, serving major operational regions across the country. DPS specialises in a comprehensive range of services, including histopathology, cytopathology, and molecular diagnostics, distinguished by their commitment to accuracy and rapid turnaround times. Their state-of-the-art laboratory facilities and a team of highly qualified pathologists ensure that clients receive unparalleled diagnostic support. With a strong market position, Diagnostic Pathology Services, Inc. has garnered recognition for its innovative approaches and dedication to quality, making it a trusted partner for healthcare providers seeking reliable pathology services.
How does Diagnostic Pathology Services, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Diagnostic Pathology Services, Inc.'s score of 11 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Diagnostic Pathology Services, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Quest Diagnostics Incorporated, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges specific to Diagnostic Pathology Services, Inc., it is important to note that emissions data and performance metrics may be inherited from its parent company, Quest Diagnostics Incorporated. This relationship suggests that any climate initiatives or targets may align with those set by Quest Diagnostics, although specific details are not provided. As a part of the healthcare sector, Diagnostic Pathology Services, Inc. operates within an industry increasingly focused on sustainability and carbon reduction. However, without specific emissions data or reduction commitments, the company's individual climate impact remains unclear.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | |
---|---|---|
Scope 1 | 238,910,000 | 000,000,000 |
Scope 2 | 107,948,000 | 00,000,000 |
Scope 3 | - | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Diagnostic Pathology Services, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.